Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2008 Jul;7(7):2090–2095. doi: 10.1158/1535-7163.MCT-07-2282

Figure 3. Sulindac and celecoxib block tumorigenesis in human uterine cancer xenografts overexpressing HMGA1a.

Figure 3

A, representative transgenic mice treated with control food or food supplemented with sulindac or celecoxib.

B, MES-SA xenografts overexpress HMGA1a mRNA compared to normal uterus or SK-UT-1 xenografts. The bars represent the mean ± SD from at least two experiments performed in triplicate. *, p < 0.05